| RS2528037788 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2528039666 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2528040305 |
NCF2
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2528040592 |
HUWE1
|
Health Risk |
Likely pathogenic |
HUWE1-related disorder, HUWE1-related disorder |
| RS2528041334 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528041770 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528041806 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528042112 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528042451 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2528043049 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2528043946 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2528045041 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528045056 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528045084 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528045266 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528045584 |
USH2A
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 39, See cases |
| RS2528045805 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528046033 |
USH2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528046063 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2528046090 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528046131 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528046144 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528046473 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome, Usher syndrome |
| RS2528046543 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528046555 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528046622 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528046708 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528046714 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528046804 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2528046838 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528046958 |
PTPRC
|
Health Risk |
Likely pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2528046959 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528047063 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528047249 |
USH2A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2528047332 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528047823 |
SDCCAG8
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 7, Bardet-Biedl syndrome 16 |
| RS2528049157 |
PTPRC
|
Health Risk |
Pathogenic |
Immunodeficiency 104, Immunodeficiency 104 |
| RS2528051422 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2528051488 |
CACNA1C
|
Health Risk |
Pathogenic/Likely pathogenic |
Long QT syndrome, Long QT syndrome |
| RS2528065309 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528065508 |
USH2A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 39, Retinitis pigmentosa 39 |
| RS2528065738 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528067118 |
UBAP2L
|
Health Risk |
Pathogenic |
— |
| RS2528074679 |
MTR
|
Health Risk |
Pathogenic |
Methylcobalamin deficiency type cblG, Methylcobalamin deficiency type cblG |
| RS2528075432 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528078602 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528087320 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2528087323 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528087514 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528087518 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528087541 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528087543 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528087981 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528088083 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528089182 |
LYST
|
Health Risk |
Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS2528103992 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528104297 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2528104465 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528104500 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528104627 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528104857 |
CRB1
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2528105698 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528105974 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528106112 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS2528106278 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528106913 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528108747 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528108972 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2528109129 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528110973 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528111983 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528112233 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528112763 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528114733 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528114749 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528114846 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528115427 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528115480 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528115827 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528118860 |
ARPC5
|
Health Risk |
Pathogenic |
Immunodeficiency 113 with autoimmunity and autoinflammation, Immunodeficiency 113 with autoimmunity and autoinflammation |
| RS2528126418 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528126432 |
USH2A
|
Health Risk |
Pathogenic |
— |
| RS2528126437 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528126640 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS2528126766 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528126907 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Usher syndrome type 2A |
| RS2528138701 |
RYR2
|
Health Risk |
Likely pathogenic |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS2528139805 |
NBAS
|
Health Risk |
Pathogenic |
— |
| RS2528139857 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2528143202 |
DDX59
|
Health Risk |
Likely pathogenic |
— |
| RS2528146464 |
NBAS
|
Health Risk |
Likely pathogenic |
— |
| RS2528146906 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528147327 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528147634 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2528148223 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Leber congenital amaurosis 8 |
| RS2528148331 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2528148484 |
CRB1
|
Health Risk |
Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS2528148933 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2528148995 |
CRB1
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 12, Leber congenital amaurosis 8 |
| RS2528149815 |
CRB1
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |